v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating activities:    
Net loss $ (11,080,380) $ (8,266,576)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization and depreciation 3,224 5,814
Non-cash lease expense 114,602 120,871
Share-based compensation 587,583 329,815
Issuance of common stock to vendors for services 76,600 15,800
Change in fair value of convertible debt   (260,933)
Change in operating assets and liabilities:    
Contracts and grants receivable   171,254
Prepaid expenses and other current assets 10,958 (39,255)
Research and development incentives receivable   48,643
Operating lease liability (114,322) (121,765)
Accounts payable and accrued expenses (16,501) (492,613)
Accrued compensation 151,683 85,327
Net cash flows from operating activities (10,266,553) (8,403,618)
Investing activities:    
Purchases of furniture and equipment (5,883)  
Net cash flows from investing activities (5,883)  
Financing activities:    
Proceeds from issuance of common stock pursuant to At Market Issuance Sales Agreement 4,666,421 1,071,559
Proceeds from issuance of common stock and pre-funded warrants 7,498,522 4,741,400
Proceeds from the exercise of warrants 305,241 4,450,172
Issuance costs associated with warrant inducement   (374,774)
Convertible debt repayments (1,372,873) (1,372,872)
Net cash flows from financing activities 10,389,075 7,762,089
Effect of exchange rate on cash and cash equivalents   14,885
Net increase (decrease) in cash and cash equivalents 116,639 (626,644)
Cash and cash equivalents at beginning of year 7,819,514 8,446,158
Cash and cash equivalents at end of year 7,936,153 7,819,514
Supplemental information:    
Cash paid for state income taxes 122,155 42,162
Cash paid for interest 35,044 227,735
Cash paid for lease liabilities:    
Operating lease 139,500 136,917
Non-cash investing and financing activities:    
Pontifax conversion of portion of debt principal into common stock   254,256
Right-of-use assets obtained in exchange for lease liabilities 360,604  
Deferred issuance cost reclassified to additional paid-in capital 103,847 250,698
Offering costs included in accounts payable and accrued expenses 67,850  
Warrant modification - incremental value   7,177,683
At Market Issuance Sales Agreement    
Financing activities:    
Stock issuance costs associated   (128,331)
Public Offering    
Financing activities:    
Stock issuance costs associated $ (708,236) $ (625,065)